| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/12/2009 | CN101502660A Medicine-carrying polylactic acid microcapsular ultrasound contrast agent and preparation method thereof |
| 08/11/2009 | US7572949 SKN-1 and GSK-3 genes and proteins |
| 08/11/2009 | US7572768 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 08/11/2009 | US7572765 polypeptides or fragments used for treating bone disorders such as osteoporosis |
| 08/11/2009 | US7572598 Preparation comprising albumin esterified with a labeled substance for diagnosis of pancreatic exocrine function |
| 08/11/2009 | US7572457 Immunoglobulins; vaccines |
| 08/11/2009 | US7572455 bovine viral diarrhea virus; point mutations; glycoproteins; RNAse inhibition |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572434 In drosophila, aplysia, and rodents; one isoform (dcreb2-a) encodes a cyclic 3',5'-adenosine monophosphate (camp)-responsive transcriptional activator, another isoform (dcreb2-b) codes for an antagonist which blocks the activator |
| 08/11/2009 | CA2391539C Use of poly(diallylamine) polymers |
| 08/11/2009 | CA2289283C Metastasis models using green fluorescent protein (gfp) as a marker |
| 08/07/2009 | CA2643611A1 Biomarkers for head-and-neck cancers and precancers |
| 08/07/2009 | CA2618163A1 Head and neck cancer biomarkers |
| 08/06/2009 | WO2009097277A1 Cationic contrast agents and methods of use thereof |
| 08/06/2009 | WO2009095516A1 Metal nanoparticles functionalised with neuropeptide vip and preparation method |
| 08/06/2009 | WO2009074811A3 Use of 5-aminolevulinic acid and derivatives in a solid form for photodynamic treatment and diagnosis |
| 08/06/2009 | WO2009057021A3 Photoacoustic imaging contrast agent and system for converting optical energy to in-band acoustic emission |
| 08/06/2009 | WO2008091530A3 Diagnostic and therapeutic cyclooxygenase-2 binding ligands |
| 08/06/2009 | WO2008036675A8 Compositions and methods of enhancing immune responses |
| 08/06/2009 | US20090196831 Nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 08/06/2009 | US20090196830 Elimination of contrast agent concentration dependency in mri |
| 08/06/2009 | US20090196829 Mri contrast agents and related methods of use |
| 08/06/2009 | US20090196828 Contrast agent comprising a tm2+ containing luminescent substance for optical imaging |
| 08/06/2009 | US20090196827 Drug Loaded Contrast Agents: Combining Diagnosis and Therapy |
| 08/06/2009 | US20090196826 Compositions and methods of making non-spherical micro- and nano-particles |
| 08/06/2009 | US20090196825 Cd38 and obesity |
| 08/06/2009 | US20090196824 Treatment of sequelae of psychiatric disorders |
| 08/06/2009 | US20090196823 Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions |
| 08/05/2009 | EP2083870A1 Multimeric particles |
| 08/05/2009 | EP2083869A2 Means and methods for cytometric therapies |
| 08/05/2009 | EP1420681A4 Peptide-based multimeric targeted contrast agents |
| 08/05/2009 | CN101500590A Antibodies and related molecules that bind to 161P2F10B proteins |
| 08/05/2009 | CN101497878A Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use |
| 08/05/2009 | CN101497656A Polypeptide with high combination activity with integrin alpha v beta 3 and use thereof |
| 08/05/2009 | CN101496906A Lipid nano granule containing magnetic resonance contrast agent as well as preparation method and use thereof |
| 08/05/2009 | CN101496905A Marker for function check of stomach and intestine and preparation method thereof |
| 08/05/2009 | CN101496904A Trichosanthin protein induced mouse allelgic asthma disease model |
| 08/04/2009 | US7569663 Genetically engineered fusion proteins for use in diagnosis and treatment of cancer, viral infections, autoimmune and alloimmune diseases |
| 08/04/2009 | US7569337 Labeling brain tissues in vivo or in vitro; 3-Benzothiazol-2-yl-7-[4-(2-fluoro-ethyl)-piperazin-1-yl]-chromen-2-one; diagnosis, monitoring the effectiveness of a therapeutic treatment and detecting histopathological hallmarks of Alzheimer's disease |
| 08/04/2009 | US7569209 Using procalcitonin concentration as diagnostic tool in detection and evaluation of systemic infection |
| 08/04/2009 | US7569208 Using carbon isotope 13C-labeled inclusion complex having cyclodextrin as host molecule and a guest molecule included to detect pancreatitis and/or pancreatic cancer |
| 08/04/2009 | CA2323090C In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 07/30/2009 | WO2009092516A2 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 07/30/2009 | WO2009047361A3 Injectable fibrin compositions for tissue augmentation comprising strontium salt |
| 07/30/2009 | WO2009004357A3 A method of hyperpolarising a magnetic resonance agent |
| 07/30/2009 | WO2008070384A3 Method of preparing macromolecular contrast agents and uses thereof |
| 07/30/2009 | WO2008055059A8 Bi-functional peptides for multiple sclerosis treatment and diagnosis |
| 07/30/2009 | US20090192505 Method for cryospray ablation |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090191131 Use of particulate contrast agents in diagnostic imaging for studying physiological paramaters |
| 07/30/2009 | US20090191130 De novo synthesis of bacteriochlorins |
| 07/30/2009 | US20090191129 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| 07/30/2009 | US20090191128 Core-shell nanoparticles for thearapy and imaging purposes |
| 07/30/2009 | US20090191127 Omentum and use thereof |
| 07/30/2009 | US20090191126 Peptide and multivalent peptide conjugate for diagnosis and treatment of vascular plaques |
| 07/30/2009 | US20090191124 PDGF-RBeta BINDERS |
| 07/30/2009 | US20090191121 Targeting and Imaging Tumor Vasculature Using Conjugates That Bind to Aminophospholipids |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/29/2009 | EP2081603A1 Fluorescent chemical sensor |
| 07/29/2009 | EP2081601A1 Dendrimeric platform for controlled release of drugs |
| 07/29/2009 | EP1885721B1 Metal chelates of polyaminocarboxylic macrocyclic derivatives and use thereof in diagnostic imaging |
| 07/29/2009 | EP1737474A4 Non-gmo metal amino acid chelates and non-gmo metal amino acid chelate-containing compositions |
| 07/29/2009 | EP1729824B1 Phospholipid analogs for the treatment of cancers |
| 07/29/2009 | EP1723252A4 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients |
| 07/29/2009 | EP1641806B1 Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders |
| 07/29/2009 | EP1455772B1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 07/29/2009 | CN100520408C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 07/28/2009 | US7566783 Long wavelength long lifetime luminophores |
| 07/28/2009 | US7566459 Which have functional lspA gene deletions; vaccines |
| 07/28/2009 | US7566444 Versatile hydrophilic dyes |
| 07/28/2009 | US7566443 Method for diagnosis of chronic allograft rejection |
| 07/28/2009 | US7566442 Emulsion; nanoparticles of liquid perfluorocarbon cores coated with lipid/surfactant coupled to integrin specific ligand; 3-({7-[(imidazol-2-ylamino)methyl]-1-methyl-4-oxo(3-hydroquinolyl)}carbonylamino)propanoic Acid adduct with Distearoyl-Glycero-3-Phosphoethanolamine-(PEG)-Maleimide deriv; nonantibody |
| 07/23/2009 | WO2009092062A2 Fluorescent imaging agents |
| 07/23/2009 | WO2009091059A1 Composition for diagnosis, treatment or prevention of epilepsy |
| 07/23/2009 | WO2009067663A8 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 07/23/2009 | WO2009066182A3 Method of treating cancer |
| 07/23/2009 | WO2009027106A3 Non-invasive in vivo imaging and methods for treating type i diabetes |
| 07/23/2009 | WO2007134166A9 Real-time detection of influenza virus |
| 07/23/2009 | WO2007110867A8 Implantable sensor |
| 07/23/2009 | US20090187998 Method of screening for agents to treat heart failure |
| 07/23/2009 | US20090187996 Ion Channel |
| 07/23/2009 | US20090187109 Method and apparatus for examining tissue for predefined target cells, particularly cancerous cells, and a probe useful in such method and apparatus |
| 07/23/2009 | US20090186839 Model for studying the role of genes in chemoresistance |
| 07/23/2009 | US20090186070 Particle immobilized coating and uses thereof |
| 07/23/2009 | US20090186060 Methods of enhancing radiation effects with metal nanoparticles |
| 07/23/2009 | US20090185980 In vivo drug screening system |
| 07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |
| 07/23/2009 | US20090185978 Monoclonal antibody capable of binding integrin alpha 10 beta 1 |
| 07/23/2009 | US20090185977 Composition and method for imaging cells |
| 07/23/2009 | US20090185976 Method for introducing a chemical agent into the systemic circulation |
| 07/23/2009 | US20090185975 Diagnostic probe for conformation disease |
| 07/23/2009 | US20090185974 Chimeric, Human and Humanized Anti-Granulocyte Antibodies and Methods of Use |
| 07/23/2009 | US20090185973 Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects |
| 07/23/2009 | CA2749108A1 Fluorescent imaging agents |
| 07/22/2009 | EP2080489A2 Apparatus for marking tissue |
| 07/22/2009 | EP2080481A1 Device for sampling or transferring to the genital organs, with enhanced ultrasound visibility |
| 07/22/2009 | EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 07/22/2009 | EP2079486A2 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 07/22/2009 | EP2079444A2 Particles for cell targeting |
| 07/22/2009 | EP1251877A4 Site specific binding system, nuclear imaging compositions and methods |